These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

74 related articles for article (PubMed ID: 4981796)

  • 21. [Use of adjuvants for obtaining antibodies against capsule polypeptides of Bacillus anthracis].
    EISNER M
    Schweiz Z Pathol Bakteriol; 1959; 22(2):129-44. PubMed ID: 13646612
    [No Abstract]   [Full Text] [Related]  

  • 22. Studies on synthetic polypeptide antigens derived from multichain polyproline. I. Immunogenic and tolerogenic capacity of antigens composed wholly or partly of D-amino acids.
    Medlín J; Humphrey JH; Sela M
    Folia Biol (Praha); 1970 Jun; 16(3):145-55. PubMed ID: 5432726
    [No Abstract]   [Full Text] [Related]  

  • 23. Passive immunotherapy of Bacillus anthracis pulmonary infection in mice with antisera produced by DNA immunization.
    Herrmann JE; Wang S; Zhang C; Panchal RG; Bavari S; Lyons CR; Lovchik JA; Golding B; Shiloach J; Lu S
    Vaccine; 2006 Jul; 24(31-32):5872-80. PubMed ID: 16790303
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Generation and characterization of monoclonal antibodies to protective antigen of Bacillus anthracis.
    Sastry KS; Tuteja U; Batra HV
    Indian J Exp Biol; 2003 Feb; 41(2):123-8. PubMed ID: 15255603
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Studies on the non-specific precipitation of basic serum proteins with gamma-glutamyl polypeptides.
    LEONARD CG; THORNE CB
    J Immunol; 1961 Aug; 87():175-88. PubMed ID: 13760920
    [No Abstract]   [Full Text] [Related]  

  • 26. Some properties of so-called anticapsular sera used in the immunofluorescent reaction with capsules of B. anthracis.
    Franĕk J; Kubin V
    J Hyg Epidemiol Microbiol Immunol; 1967; 11(3):325-9. PubMed ID: 4980471
    [No Abstract]   [Full Text] [Related]  

  • 27. Modification of antigenic structure in vivo: quantitative studies on the processing of streptococcal cell wall antigens in mice.
    Schwab JH; Brown RR
    J Immunol; 1968 Nov; 101(5):930-8. PubMed ID: 4235135
    [No Abstract]   [Full Text] [Related]  

  • 28. [Immunogenicity of the recombinant Bacillus strains with cloned gene of biosynthesis of protective antigen against Bacillus anthracis].
    Mikshis NI; Kudriavtseva OM; Bolothikova MF; Shulepov DV; Novikova LV; Popov IuA; Shchukovskaia TN; Drozdov IG; Kutyrev VV
    Mol Gen Mikrobiol Virusol; 2007; (3):15-21. PubMed ID: 17886469
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Enhancement of systemic immune response by immunization into chronically inflamed lungs.
    Yoshizawa Y; Hostetter MW; Nakazawa T; Ripani LM; Dawson CA; Moore VL
    J Lab Clin Med; 1982 Jul; 100(1):61-9. PubMed ID: 7045259
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Immunogenicity of a subunit vaccine against Bacillus anthracis.
    Chichester JA; Musiychuk K; de la Rosa P; Horsey A; Stevenson N; Ugulava N; Rabindran S; Palmer GA; Mett V; Yusibov V
    Vaccine; 2007 Apr; 25(16):3111-4. PubMed ID: 17280756
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Identification and characterization of immunodominant B-cell epitope of the C-terminus of protective antigen of Bacillus anthracis.
    Kaur M; Chug H; Singh H; Chandra S; Mishra M; Sharma M; Bhatnagar R
    Mol Immunol; 2009 Jun; 46(10):2107-15. PubMed ID: 19356802
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Electric energy as a lethal lytic and antigen-extractive agent for bacterial cell. II. The antigen-extractive action, with special reference to the possibility of differentiating the vegetative and the spore antigens in Bacillus anthracis.
    SUGIYAMA T
    Kitasato Arch Exp Med; 1953 Nov; 26(2-3):177-83. PubMed ID: 14382306
    [No Abstract]   [Full Text] [Related]  

  • 33. Generation of mouse polyclonal and human monoclonal antibodies against Bacillus anthracis toxin.
    Huber M; Vor Dem Esche U; Grunow R; Bessler WG
    Drugs Exp Clin Res; 2005; 31(2):35-43. PubMed ID: 15929604
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Synthesis and antigenic analysis of the BclA glycoprotein oligosaccharide from the Bacillus anthracis exosporium.
    Mehta AS; Saile E; Zhong W; Buskas T; Carlson R; Kannenberg E; Reed Y; Quinn CP; Boons GJ
    Chemistry; 2006 Dec; 12(36):9136-49. PubMed ID: 17133642
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Development of novel vaccines against anthrax in man.
    Stepanov AV; Marinin LI; Pomerantsev AP; Staritsin NA
    J Biotechnol; 1996 Jan; 44(1-3):155-60. PubMed ID: 8717399
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [Resorption, distribution and excretion after administration of 14C-labelled HB 419 in rabbits, rats and dogs].
    Kellner HM; Christ O; Rupp W; Heptner W
    Arzneimittelforschung; 1969 Aug; 19(8):Suppl:1388+. PubMed ID: 5394459
    [No Abstract]   [Full Text] [Related]  

  • 37. Linear polypeptides of a known primary structure. Synthesis and immunochemical studies of poly(L-glutamyl-L-tyrosyl-L-alanylglycyl)glycine-1-14C ethyl ester.
    Johnson BJ
    J Med Chem; 1971 Jun; 14(6):488-9. PubMed ID: 5091963
    [No Abstract]   [Full Text] [Related]  

  • 38. [Studies on release mechanism of bactericidins from blood platelets (author's transl)].
    Ishibashi A; Ishibashi T; Hiruma T; Uchiyama H; Mochida H
    Nihon Saikingaku Zasshi; 1979 Sep; 34(5):731-43. PubMed ID: 118274
    [No Abstract]   [Full Text] [Related]  

  • 39. Immunochemical specificity: recent conceptual advances.
    Goodman JW
    Immunochemistry; 1969 Jan; 6(1):139-49. PubMed ID: 4974990
    [No Abstract]   [Full Text] [Related]  

  • 40. The biosynthesis of poly d-glutamic acid, the capsular material of Bacillus anthracis.
    Meynell GG; Meynell E
    J Gen Microbiol; 1966 Apr; 43(1):119-38. PubMed ID: 4959278
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 4.